Skip to content

Basket

You currently have no items in your basket.

Total (excl. vat) £0.00
View basket & checkout
Antibodies

Anti-ROR2 Reference Antibody (ozuriftamab vedotin)

Product Sizes
100 ug
£635.00
CHB264-100UG
1 mg
£2295.00
CHB264-1MG
About this Product
SKU:
CHB264
Additional Names:
IgG1|ozuriftamab vedotin
Application:
Cell-based/Functional Assay, Detection/Quantitation, ELISA, FACS, Flow Cytometry
Buffer:
25mM histidine, 8% sucrose, 0.01% Tween80 pH6.2
Clonality:
Recombinant Monoclonal
Concentration:
1 mg/ml
Extra Details:
Ozuriftamab vedotin is an ADC consisting of a ROR2-directed antibody and Monomethyl auristatin E (MMAE) used for the study of several solid tumors.
Formulation:
25mM histidine, 8% sucrose, 0.01% Tween80 pH6.2
Immunogen:
ROR2
Isotype:
IgG1
Physical State:
Lyophilized
Purity:
>90%
Reactivities:
Human
Shipping Conditions:
Blue Ice
Specificity:
ROR2
Storage Conditions:
-70[o]C Avoid freeze/thaw cycles., 2-8[o]C
Supplier:
Sanyou Biopharmaceuticals
Type:
Antibody: Biosimilar Antibody
  • Manufacturer's Data Sheet:CHB264
Anti-ROR2 Reference Antibody (ozuriftamab vedotin) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.
The purity of Anti-ROR2 Reference Antibody (ozuriftamab vedotin) is 99.74%, determined by SEC-HPLC.
The drug-to-antibody ratio (DAR) of the Anti-ROR2 Reference Antibody (ozuriftamab vedotin) is 3.9.
Immobilized ROR2 at 2 ug/mL (30 uL/well) can bind Anti-ROR2 Reference Antibody (ozuriftamab vedotin), EC50 is 0.160 ug/mL.
Human ROR2 CHO-S Cell Line were stained with Anti-ROR2 Reference Antibody (ozuriftamab vedotin) and negative control protein respectively, washed and then followed by PE and analyzed with FACS,The EC50 is 0.2650 ug/mL.